The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer

Gabrielle Colleran; Niall Mcinerney; Andrew Rowan; Ella Barclay; Angela M. Jones; Catherine Curran; Nicola Miller; Michael Kerin; Ian Tomlinson; Elinor Sawyer

doi:10.1007/s10549-009-0395-0

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer

Gabrielle Colleran
, Niall Mcinerney
, Andrew Rowan
, Ella Barclay
, Angela M. Jones
, Catherine Curran
, Nicola Miller
, Michael Kerin
, Ian Tomlinson
, Elinor Sawyer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	437-442
Journal	Breast cancer research and treatment
Volume	119
Issue number	2
DOIs	https://doi.org/10.1007/s10549-009-0395-0
Publication status	Published - 1 Jan 2010

Access to Document

10.1007/s10549-009-0395-0

http://link.springer.com/10.1007/s10549-009-0395-0

Cite this

@article{38edd62417c1450cbad1a43882e77883,

title = "The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer",

author = "Gabrielle Colleran and Niall Mcinerney and Andrew Rowan and Ella Barclay and Jones, \{Angela M.\} and Catherine Curran and Nicola Miller and Michael Kerin and Ian Tomlinson and Elinor Sawyer",

year = "2010",

month = jan,

day = "1",

doi = "10.1007/s10549-009-0395-0",

language = "English",

volume = "119",

pages = "437--442",

journal = "Breast cancer research and treatment",

issn = "0167-6806",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer

AU - Colleran, Gabrielle

AU - Mcinerney, Niall

AU - Rowan, Andrew

AU - Barclay, Ella

AU - Jones, Angela M.

AU - Curran, Catherine

AU - Miller, Nicola

AU - Kerin, Michael

AU - Tomlinson, Ian

AU - Sawyer, Elinor

PY - 2010/1/1

Y1 - 2010/1/1

U2 - 10.1007/s10549-009-0395-0

DO - 10.1007/s10549-009-0395-0

M3 - Article

SN - 0167-6806

VL - 119

SP - 437

EP - 442

JO - Breast cancer research and treatment

JF - Breast cancer research and treatment

IS - 2

ER -